About
Cullinan Oncology Llc (NASDAQ:CGEM) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 10 2026
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 5 2026
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026
Jan 12 2026
Adimab Reports Strong Partnering Year for 2025
Jan 8 2026
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
Dec 8 2025
Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting
Financials
Revenue
$0
Market Cap
$873.39 M
EPS
-3.36
Google Übersetzer